Profile
ARTV VRTX ALNY REGN ARGX SGEN
Company Name Artiva Biotherapeutics, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $64.97M $101.65B $61.42B $57.97B $46.70B $43.15B
Employees 0.10K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Fred Aslan Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ARTV VRTX ALNY REGN ARGX SGEN
Quant Rating Score 3 4 1 4 4 3
Quant Rating Neutral Buy Strong Sell Buy Buy Neutral
Trading
ARTV VRTX ALNY REGN ARGX SGEN
Last Close $2.66 $397.37 $468.58 $568.2 $763.52 $228.74
High 52 $15.83 $516.74 $482.13 $1164.46 $768 $228.74
Low 52 $1.47 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -83.2 % -23.1 % -2.81 % -51.2 % -0.58 % 0 %
Price vs. 52 Week Low 80.95 % 8.41 % 108.65 % 17.66 % 46.9 % 0 %
Total Return
ARTV VRTX ALNY REGN ARGX SGEN
1 Month Return 7.69 % 2.48 % 8.99 % 2.09 % 19.76 % 0 %
3 Month Return 29.13 % -13.63 % 53.8 % 8.9 % 30.12 % 0 %
6 Month Return -57.51 % -19.79 % 93.29 % -17.59 % 29.09 % 0 %
9 Month Return -74.95 % -14.31 % 90.91 % -22.3 % 25.74 % 0 %
YTD Return -73.61 % -1.32 % 99.13 % -20.23 % 24.15 % 0 %
1 Year Return -75.23 % -16.98 % 79.03 % -51.2 % 42.51 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ARTV VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -40.03 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
ARTV VRTX ALNY REGN ARGX SGEN
Asset Growth 99.38 % -0.87 %
Gross Profit Growth -99.25 % 10.25 %
Revenue Growth -99.25 % 11.66 %
Revenue 3 Year -80.42 % 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -119.37 % -93.69 %
Net Income Growth -111.2 % -114.8 %
Net Income 3 Yeari Growth Per Share -27.18 % -122.89 %
Net Income 5 Yeari Growth Per Share - -145.38 %
Net Income 10 Yeari Growth Per Share - 33.84 %
Operating Income Growth -119.37 % -106.08 %
Operating Cash Flow Growth (CFG) -16.03 % -113.93 %
Operating 3 Year CFG -461.59 % -118.65 %
Operating 5 Year CFG - -131.3 %
Operating 10 Year CFG - 12.43 %
EPS Growth -336.97 % -114.8 %
EPS Diluted Growth -336.97 % -114.97 %
Book Value Per Share 338.22 % -6.59 %
Share Holder 3 Year Equity Growth Per Share 428.03 % 62.6 %
Share Holder 5 Year Equity Growth Per Share - 168.85 %
Share Holder 10 Year Equity Growth Per Share - 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -15.13 % 116.42 %
Free Cash Flow Growth -9.84 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ARTV VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -40.29 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -38.7 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -51.43 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 83.66 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -522.42 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.83 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -2.9 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 583.97 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.5 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -522.42 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.92 29.05 -1179.18 15.08 -593.84 -81.26
Price To Operating Cash Flows Ratio TTM -0.94 26.46 -3910.39 12.33 -703.98 -93.1
Price Cash Flow Ratio TTM -0.94 26.46 -3910.39 12.33 -703.98 -93.1
Income Statement (TTM)
ARTV VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.06B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.06B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -5.2 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ARTV VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.01B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.02B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.19B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.15B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.21B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ARTV VRTX ALNY REGN ARGX SGEN
Net Income $-0.07B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.52
AARD Aardvark Therapeutics, Inc. Common Stock 8.66
ABCL AbCellera Biologics Inc. 4.46
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.425
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.3
ABPWW 0.0463
ABSI Absci Corporation 2.555
ABUS Arbutus Biopharma Corporation 4.47
ABVC ABVC BioPharma, Inc. 2.85
ABVX Abivax SA American Depositary Shares 84.02
ACAD ACADIA Pharmaceuticals Inc. 23.615
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8102
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.075
ACIU AC Immune SA 2.43
ETFs With Exposure to ARTV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0001 238.34
VTI Vanguard Total Stock Market Index Fund 0 324.34
IBB iShares Biotechnology ETF 0.00318 140.955
IWN iShares Russell 2000 Value ETF 0.00011 175.57
IWO iShares Russell 2000 Growth ETF 0.00013 312.95
BIB ProShares Ultra Nasdaq Biotechnology 0.00395968 57.21
VXF Vanguard Extended Market Index Fund 0.00053 208.88
HDG ProShares Hedge Replication ETF 0.000167861 51.15
UWM ProShares Ultra Russell2000 0.000980364 45.09
VTHR Vanguard Russell 3000 Index Fund 0 290.94
IWC iShares Micro-Cap ETF 0.00284 145.79
URTY ProShares UltraPro Russell2000 0.000784157 50.78
VTWV Vanguard Russell 2000 Value Index Fund 0.00152 154.85
VTWG Vanguard Russell 2000 Growth Index Fund 0.0017 228.63
VTWO Vanguard Russell 2000 Index Fund 0.00151 96.41
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 45.43
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00007 110.47
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.45
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.38
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.37
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.37
IBBQ Invesco Nasdaq Biotechnology ETF 0.006 23.82
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00593 5.973
VTSAX Vanguard Total Stock Market Index Fund 0 158.11
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00593 6.995
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00053 159.98
VITSX Vanguard Total Stock Market Index Fund 0 158.13
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.00593 6.971
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00053 159.99
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00593 5.16375
VTS.AX Vanguard US Total Market Shares Index ETF 0 488
VEMPX Vanguard Extended Market Index InstlPlus 0.00053 394.8
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 296.65
RSSL Global X Funds 0 93.67
Unlock